COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s): CSCI

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:CSCI - Post by User

COSCIENS Biopharma Inc > Email Response from Gilles Gagnon on March 12, 2024

<< Previous

Bullboard Posts

Next >>

Post by oatson Nov 21, 2024 10:48am

97 Views

Post# 36323758

Email Response from Gilles Gagnon on March 12, 2024

Below is the response that Gilles Gagnon provided on March 12, 2024 with regards to my message to him regarding the Merger:

Hi XXXXXX,
While I read that you will never forgive me and the board for what you are expressing, I wish that you will never forget me and the board for what we are creating today. I will make sure that in a few years, you will remember having supported a guy who will have paved the way for the building of a very solid company and created a lot of value for your investment. You will have given hell to this guy from time to time but he “stayed the course and made it for us”.
You will be part of this success story.
Gilles

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant